Emanuele Raso | Medical Devices | Best Researcher Award

Published on by World Top Scientists

Dr. Emanuele Raso | Medical Devices | Best Researcher Award

Research Fellow at University of Rome Tor Vergata, Italy

Emanuele Raso is a Research Fellow at the University of Rome Tor Vergata, specializing in cybersecurity within the Department of Electronic Engineering. He holds a Ph.D. in Computer Science, Control, and Geoinformation and focuses on applied cryptography, data privacy, open-source intelligence, and the use of artificial intelligence in the medical domain. His work is dedicated to developing secure data processing systems and privacy-preserving technologies, particularly for healthcare and critical digital infrastructure. Raso has contributed to several national and European research projects, including BPR4GDPR, I-NEST, Rome Technopole, and ISP5G+, and has published 16 Scopus-indexed journal articles. He serves as a guest editor for the MDPI Sensors journal’s special issue on cybersecurity in healthcare and is affiliated with CNIT’s National Laboratory of Network Assessment, Assurance, and Monitoring. His interdisciplinary research bridges engineering, cybersecurity, and healthcare, making significant strides in protecting sensitive data in increasingly digital health systems.

Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile 

Education

Emanuele Raso earned his Ph.D. in Computer Science, Control, and Geoinformation from the University of Rome Tor Vergata, where he also completed his earlier academic training. His doctoral work laid the foundation for his current research in cybersecurity, with a focus on secure and privacy-preserving technologies. Through his education, Raso developed a strong technical background in applied cryptography, artificial intelligence, and data privacy—areas critical to safeguarding modern digital infrastructures. His academic path demonstrates a consistent alignment with emerging technological challenges, particularly in the intersection of computing and healthcare. His education also reflects rigorous interdisciplinary training, incorporating both theoretical knowledge and practical implementation strategies in secure systems. This comprehensive academic preparation has enabled him to contribute effectively to national and European research initiatives, and to innovate in fields that bridge computer science and real-world societal applications, especially in the secure handling of sensitive health-related data.

Professional Experience

Emanuele Raso is currently a Research Fellow in the Department of Electronic Engineering at the University of Rome Tor Vergata. In this role, he has been actively involved in both academic and applied research focused on cybersecurity, with an emphasis on data privacy and secure computing environments. His professional experience includes participation in several high-profile European and national research projects such as BPR4GDPR, I-NEST, Rome Technopole, and ISP5G+. These projects have given him the opportunity to work on developing privacy-preserving technologies for healthcare and critical infrastructures. Although he does not yet have consultancy or industrial project experience, his academic roles have involved extensive research, collaboration, and knowledge dissemination. As a guest editor for MDPI Sensors, he contributes to the academic peer-review process, and he maintains active affiliations with professional research bodies like CNIT’s NAM LAB. His professional career reflects a growing influence in cybersecurity research with practical societal applications.

Research Interest

Emanuele Raso’s primary research interests lie in cybersecurity, particularly in applied cryptography, data privacy and confidentiality, open-source intelligence (OSINT), and the integration of artificial intelligence in the medical domain. His work is motivated by the growing need for secure digital environments, especially in critical sectors such as healthcare, where the protection of sensitive personal and clinical data is paramount. He is particularly focused on developing privacy-preserving technologies and secure data processing frameworks that ensure confidentiality without sacrificing functionality. His interdisciplinary approach bridges the gap between computer science and digital health, aiming to create systems that support compliance with regulations like GDPR while fostering innovation in medical data analysis. Raso is also interested in the ethical and social implications of AI-driven decision-making systems, especially in healthcare contexts. This forward-thinking research orientation enables him to address contemporary challenges at the nexus of cybersecurity, data science, and digital health infrastructure.

Award and Honor

While Emanuele Raso has not listed major individual awards or honors in his profile, his appointment as a Guest Editor for the Sensors journal’s special issue on “Cybersecurity in Healthcare and Medical Devices” is a notable academic distinction. This editorial role highlights his recognized expertise and growing reputation within the cybersecurity and health informatics research communities. Additionally, his active participation in prestigious European research projects such as BPR4GDPR and I-NEST reflects a high level of professional trust and recognition in his field. His affiliation with CNIT’s NAM LAB, a national network of telecommunications researchers, also signifies his integration into Italy’s leading research bodies. Though formal awards may yet be forthcoming in his career, these appointments and roles affirm the esteem in which he is held by colleagues and research institutions. They demonstrate his trajectory as a respected contributor in applied cybersecurity and health technology fields.

Conclusion

Emanuele Raso is an emerging expert in cybersecurity, with a strong academic background, active professional research engagements, and a focused interest in privacy-preserving technologies for healthcare and critical infrastructures. His work addresses timely and vital challenges in safeguarding sensitive information in an increasingly digital world, particularly at the intersection of artificial intelligence and health data management. Although his profile does not currently include industry collaborations or major awards, his contributions to high-level European projects and his editorial role underscore his growing impact in the field. With a solid foundation in computer science and a strong commitment to interdisciplinary innovation, Raso is well-positioned to make significant advancements in secure computing environments. His research is not only academically relevant but also societally impactful, with real-world applications in digital health systems. As his career progresses, he is likely to expand his influence further and become a key figure in shaping the future of cybersecurity in healthcare.

Publications Top Notes

  • Title: Privacy-aware architectures for NFC and RFID sensors in healthcare applications
    Authors: E. Raso, G.M. Bianco, L. Bracciale, G. Marrocco, C. Occhiuzzi, P. Loreti
    Year: 2022
    Citations: 16

  • Title: Privacy and transparency in blockchain-based smart grid operations
    Authors: P. Loreti, L. Bracciale, E. Raso, G. Bianchi, E.R. Sanseverino, P. Gallo
    Year: 2023
    Citations: 12

  • Title: UHF RFID and NFC point-of-care—Architecture, security, and implementation
    Authors: G.M. Bianco, E. Raso, L. Fiore, V. Mazzaracchio, L. Bracciale, F. Arduini, …
    Year: 2023
    Citations: 11

  • Title: An SDN-based traffic handover control procedure and SGD management logic for EHF satellite networks
    Authors: M.M. Aurizzi, T. Rossi, E. Raso, L. Funari, E. Cianca
    Year: 2021
    Citations: 10

  • Title: A privacy-preserving blockchain solution to support demand response in energy trading
    Authors: L. Bracciale, P. Loreti, E. Raso, G. Bianchi, P. Gallo, E.R. Sanseverino
    Year: 2022
    Citations: 8

  • Title: Anonymization and pseudonymization of FHIR resources for secondary use of healthcare data
    Authors: E. Raso, P. Loreti, M. Ravaziol, L. Bracciale
    Year: 2024
    Citations: 6

  • Title: ABEBox: A data driven access control for securing public cloud storage with efficient key revocation
    Authors: E. Raso, L. Bracciale, P. Loreti, G. Bianchi
    Year: 2021
    Citations: 6

  • Title: Performance evaluation of cryptographic schemes for blockchain security of smart grids
    Authors: E. Raso, L. Bracciale, P. Gallo, G. Bernardinetti, G. Bianchi, E.R. Sanseverino, …
    Year: 2022
    Citations: 4

  • Title: Privacy in blockchain-based smart grids
    Authors: L. Bracciale, E. Raso, P. Gallo, E.R. Sanseverino, G. Bianchi, P. Loreti
    Year: 2022
    Citations: 4

  • Title: GDPR compliance made easier: The BPR4GDPR project
    Authors: G. Lioudakis, E. Papagiannakopoulou, M. Koukovini, N. Dellas, …
    Year: 2021
    Citations: 4

  • Title: Toolate: cryptographic data access control for offline devices through efficient key rotation
    Authors: L. Bracciale, P. Loreti, E. Raso, G. Bianchi
    Year: 2021
    Citations: 4

Dr. Laura Cerchia | translational cancer research | Best Researcher Award

Published on by World Top Scientists

Dr. Laura Cerchia | translational cancer research | Best Researcher Award

PI, Group Leader at Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore”, National Research Council, Italy

Dr. Laura Cerchia is a leading researcher in cancer-targeting RNA aptamer technologies, serving as Group Leader at the Institute of Endotypes in Oncology, Metabolism and Immunology (CNR, Italy). She pioneered the cell-SELEX method, widely adopted across international labs, and developed multiple aptamers targeting tumor biomarkers such as EGFR, AXL, and PDGFRβ. These aptamers have significant applications in imaging, immunotherapy, and targeted drug delivery, with some now used globally in advanced nanomedicine platforms. Author of over 90 peer-reviewed publications with an H-index of 36, she also holds four international patents. Dr. Cerchia has received numerous grants and serves on several national and international scientific committees, including Horizon Europe’s PHIRE project. Her expertise is recognized through roles as evaluator, editorial board member, and scientific advisor. Her work bridges fundamental research and therapeutic innovation, making her a key figure in translational oncology and a strong candidate for the Best Researcher Award.

Professional Profile 

Scopus Profile
ORCID Profile 

Education

Dr. Laura Cerchia earned her PhD in Biochemical Sciences, building a strong academic foundation in molecular biology and biochemistry. Her educational background equipped her with expertise in RNA biology, molecular diagnostics, and therapeutic development. Her advanced training allowed her to explore the structural and functional aspects of nucleic acids, which later became central to her innovative work in aptamer development. During her academic years, she developed an early interest in translational research, which led her to specialize in the design of synthetic oligonucleotides for medical applications. Her doctoral and postdoctoral studies laid the groundwork for her pioneering approach in using aptamers for targeted cancer therapy. Her education not only deepened her scientific knowledge but also instilled a critical problem-solving mindset that continues to influence her research directions. Her scholarly path reflects a combination of academic rigor and innovative thinking, forming the basis for her future contributions to biomedical science.

Professional Experience

Dr. Laura Cerchia is currently Group Leader at the Institute of Endotypes in Oncology, Metabolism and Immunology “G. Salvatore” (IEOMI) within the National Research Council of Italy (CNR). Her professional journey has been marked by impactful roles in both scientific leadership and collaborative research. She developed the widely used cell-SELEX procedure and generated several clinically relevant RNA aptamers targeting key tumor markers. Beyond laboratory research, Dr. Cerchia serves on editorial boards of journals such as Scientific Reports and Molecules, and holds evaluative and advisory roles in national and international research bodies, including the Horizon Europe-funded PHIRE project. Her career reflects a balance of scientific innovation, project management, and institutional leadership. She has successfully secured multiple research grants, built interdisciplinary teams, and advanced new diagnostic and therapeutic approaches. Her professional experience showcases her ability to lead complex research initiatives and influence the broader scientific and clinical communities.

Research Interest

Dr. Cerchia’s research focuses on the development of nuclease-resistant RNA aptamers for cancer theranostics, therapeutics, and targeted drug delivery. She is especially interested in the use of aptamers as precision tools for recognizing and binding specific biomarkers in tumors, such as EGFR, AXL, and PDGFRβ. Her work involves designing aptamers that can be used for in vitro and in vivo imaging, antagonistic therapies, and as carriers for chemotherapeutics, small molecule inhibitors, siRNAs, or photosensitizers. Her innovations in cell-SELEX have enabled the selection of highly specific aptamers against aggressive cancer types like glioblastoma, NSCLC, and triple-negative breast cancer (TNBC). She is also exploring the potential of aptamers in immunotherapy, including their integration with nanomedicine platforms. Her interest lies in translating basic molecular discoveries into clinical applications, with a strong focus on personalized medicine. Overall, her research aims to bridge gaps between molecular biology, oncology, and therapeutic delivery systems.

Award and Honor

Dr. Laura Cerchia has received multiple national and international recognitions for her contributions to cancer research and aptamer technology. She is the recipient of prestigious research grants and has been invited to serve on scientific evaluation panels, including for the Wellcome Trust (UK), ANR SHAMS, PRIN, and Horizon Europe projects. In 2018, she achieved the National Scientific Qualification, allowing her to function as a Full Professor in general and clinical pathology within Italian universities—an acknowledgment of her academic and professional excellence. She also serves as President and expert evaluator for PRIN 2022 PNRR – ERC Sector LS1, reinforcing her leadership role in shaping national research priorities. Her aptamers are cited and utilized worldwide, further validating the high translational value of her work. In addition to her editorial board positions, these honors demonstrate her broad influence, scientific credibility, and sustained contributions to advancing biomedical research on both national and international levels.

Conclusion

Dr. Laura Cerchia exemplifies the qualities of a world-class biomedical researcher through her pioneering work in RNA aptamer technologies, extensive publication record, and active leadership in the international scientific community. With a robust educational background, decades of impactful professional experience, and deep research expertise, she has made significant contributions to translational cancer therapy. Her innovations have enabled more precise targeting of tumors, enhancing both diagnostic and therapeutic capabilities. Her work has not only influenced academic circles but also spurred technological advances in nanomedicine and drug delivery. The widespread adoption of her aptamers across global research groups attests to the relevance and utility of her discoveries. Coupled with numerous awards, advisory roles, and editorial contributions, her profile reflects excellence, leadership, and a forward-looking vision in biomedical science. Dr. Cerchia’s continued efforts make her a strong candidate for high honors such as the Best Researcher Award and a role model in scientific innovation.

Publications Top Notes

  • Title: A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling
    Authors: Not listed
    Year: 2025

  • Title: A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growth
    Authors: Not listed
    Year: 2025

  • Title: Preclinical Toxicological Characterization of Porphyrin-Doped Conjugated Polymer Nanoparticles for Photodynamic Therapy
    Authors: Not listed
    Year: 2025

  • Title: Urine-Stable Aptamer-Conjugated Gold Nanorods for the Early Detection of High-Grade Bladder Cancer Residual Disease
    Authors: Not listed
    Year: 2025
    Citations: 1

  • Title: Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
    Authors: Not listed
    Year: 2024
    Citations: 11

  • Title: Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
    Authors: Not listed
    Year: Not available
    Citations: 6

  • Title: Subtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression
    Authors: Not listed
    Year: Not available
    Citations: 2

  • Title: Correction to: Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids
    Authors: Not listed
    Year: 2024

  • Title: Correction to: Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles
    Authors: Not listed
    Year: 2022
    Citations: 1

Yunlong Liu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by World Top Scientists

Dr. Yunlong Liu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

lecturer at Tiangong university, China

Dr. Yunlong Liu is a distinguished structural biologist specializing in transcriptional regulation and nuclear receptor mechanisms. He is currently a Lecturer at Tiangong University, where he contributes to cutting-edge research in biochemistry and molecular biology. His expertise lies in protein structure determination, molecular interactions, and drug discovery, particularly in identifying potent inhibitors for nuclear receptors. With multiple high-impact publications, including Nucleic Acids Research and Cell Discovery, Dr. Liu has established himself as a promising researcher in his field. He has secured national-level research funding and actively contributes to prestigious scientific projects. Recognized for his academic excellence, he has received numerous awards, including the Outstanding Doctoral Dissertation Award and National Ph.D. Scholarship. His work not only advances fundamental biological understanding but also holds potential for therapeutic applications. With a strong foundation in research and teaching, Dr. Liu continues to make significant contributions to the field of structural biology.

Professional Profile

Education

Dr. Yunlong Liu completed his Ph.D. in Biochemistry and Molecular Biology at China Agricultural University in 2023, where he conducted groundbreaking research on structural biology and transcriptional regulation. His doctoral work involved the determination of multiple protein and nucleic acid complex structures, providing critical insights into nuclear receptor function. During his Ph.D., he was recognized for his exceptional academic performance, receiving the Outstanding Doctoral Dissertation Award and National Ph.D. Scholarship. Prior to his doctoral studies, he earned his undergraduate degree from a prestigious institution, excelling in both coursework and research. His academic journey has been marked by a strong emphasis on molecular mechanisms and protein interactions, laying the foundation for his current research. With a solid background in structural biology and biochemistry, Dr. Liu has developed expertise in crystallography, molecular modeling, and drug discovery, positioning him as a leading researcher in his field.

Professional Experience

Dr. Yunlong Liu is currently a Lecturer in the College of Life Sciences at Tiangong University, where he teaches and mentors students in biochemistry and molecular biology. Before this role, he conducted extensive doctoral research at China Agricultural University, focusing on protein structural analysis and transcriptional regulation. His research contributions include the identification of a highly potent nuclear receptor inhibitor and the resolution of multiple protein-DNA complex structures. As a key member of several national research projects, he has played an instrumental role in advancing molecular biology research in China. He has also secured independent research funding, serving as the Principal Investigator for a National Natural Science Foundation of China project. His professional experience extends beyond academia, as his research findings have implications for pharmaceutical development and biomedical sciences. Through his teaching and research, Dr. Liu continues to shape the next generation of scientists while making significant contributions to his field.

Research Interests

Dr. Yunlong Liu’s research focuses on the molecular mechanisms of transcriptional regulation, nuclear receptor functions, and protein-nucleic acid interactions. His work in structural biology involves determining the 3D structures of key biomolecules using advanced crystallography techniques, providing crucial insights into gene regulation and disease pathways. He is particularly interested in studying nuclear receptors and their role in gene expression, with the aim of identifying novel therapeutic targets for metabolic and genetic disorders. His research has led to the discovery of a nuclear receptor inhibitor with significantly enhanced efficacy, highlighting the potential for drug development. Additionally, he explores epigenetic modifications and their structural basis, contributing to the broader understanding of gene regulation. With a strong commitment to advancing biomedical research, Dr. Liu continues to explore new methodologies and collaborative approaches to address fundamental questions in biochemistry and molecular biology.

Awards and Honors

Dr. Yunlong Liu has been widely recognized for his outstanding contributions to structural biology and molecular research. He received the Outstanding Doctoral Dissertation Award from China Agricultural University, an honor granted to only one recipient in his college. His academic excellence also earned him the National Ph.D. Scholarship, where he ranked second in his college. Throughout his career, he has been involved in prestigious research projects funded by national and provincial organizations, including the National Natural Science Foundation of China and the Tianjin Top Scientist Studio Program. His achievements in protein structure determination and transcriptional regulation have led to publications in top-tier journals such as Nucleic Acids Research and Cell Discovery. His early accomplishments include awards in mathematical modeling competitions and national scholarships during his undergraduate studies. With a track record of excellence, Dr. Liu continues to receive accolades for his impactful research and academic contributions.

Conclusion

Dr. Yunlong Liu is a strong candidate for the Best Researcher Award, given his high-impact research, prestigious awards, and leadership in structural biology. His work in transcriptional regulation and nuclear receptors is scientifically significant and widely recognized. Strengthening international collaborations, expanding independent funding, and showcasing mentorship contributions could further elevate his standing.

Publications Top Noted

1. Nucleic Acid-Based Therapies

  • Title: The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
  • Authors: Liu, Y., Wang, C., Fu, X., & Ren, M.
  • Year: 2025
  • Journal: Biomolecules
  • DOI: 10.3390/biom15030376

2. Nucleic Acid Recognition and 6mA Demethylation

  • Title: Structural Basis of Nucleic Acid Recognition and 6mA Demethylation by Caenorhabditis elegans NMAD-1A
  • Authors: Shang, G., Yang, M., Li, M., Ma, L., Liu, Y., Ma, J., Chen, Y., Wang, X., Fan, S., Xie, M., et al.
  • Year: 2024
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms25020686

3. Transcriptional Regulation and Structural Insights

  • Title: Structures of Human TR4LBD–JAZF1 and TR4DBD–DNA Complexes Reveal the Molecular Basis of Transcriptional Regulation
  • Authors: Liu, Y., Ma, L., Li, M., Tian, Z., Yang, M., Wu, X., Wang, X., Shang, G., Xie, M., Chen, Y., et al.
  • Year: 2023
  • Journal: Nucleic Acids Research
  • DOI: 10.1093/nar/gkac1259

4. Molecular Recognition of Nucleosomes

  • Title: Structures of MPND Reveal the Molecular Recognition of Nucleosomes
  • Authors: Yang, M., Li, X., Tian, Z., Ma, L., Ma, J., Liu, Y., Shang, G., Liang, A., Wu, W., Chen, Z.
  • Year: 2023
  • Journal: International Journal of Molecular Sciences
  • DOI: 10.3390/ijms24043368

5. Epigenetic Functions and Nucleic Acid Repair

  • Title: Structural Insights into the Interactions and Epigenetic Functions of Human Nucleic Acid Repair Protein ALKBH6
  • Authors: Ma, L., Lu, H., Tian, Z., Yang, M., Ma, J., Shang, G., Liu, Y., Xie, M., Wang, G., Wu, W., et al.
  • Year: 2022
  • Journal: Journal of Biological Chemistry
  • DOI: 10.1016/j.jbc.2022.101671

6. Protein-DNA Complex and Recognition Mechanisms

  • Title: Crystal Structures of REF6 and Its Complex with DNA Reveal Diverse Recognition Mechanisms
  • Authors: Tian, Z., Li, X., Li, M., Wu, W., Zhang, M., Tang, C., Li, Z., Liu, Y., Chen, Z., Yang, M., et al.
  • Year: 2020
  • Journal: Cell Discovery
  • DOI: 10.1038/s41421-020-0150-6